Experimental group:Camrelizumab combined with chemotherapy

5 trials

Conditions

???Initially unresectable non-small cell lung cancer patientsLung cancer patients with inactive tuberculosisesophageal cancerextensive-stage small cell lung cancer

Early Phase 1

An exploratory clinical study of karelizumab combined with chemotherapy in the treatment of unresectable non-small cell lung cancer with pleural effusion

RecruitingChiCTR2100042210

Affiliated Cancer Hospital of Harbin Medical UniversityInitially unresectable non-small cell lung cancer patients

Start: 2021-01-19Updated: 2021-04-19

Phase 2

An exploratory clinical study of karelizumab combined with chemotherapy in the treatment of lung cancer patients with inactive pulmonary tuberculosis

RecruitingChiCTR2000041449

Heilongjiang Infectious Disease Prevention and Control HospitalLung cancer patients with inactive tuberculosis

Start: 2020-12-30Updated: 2021-03-15

Camrelizumab combined with chemotherapy in the treatment of second-line and above extensive-stage small cell lung cancer: an exploratory clinical study

RecruitingChiCTR2100044300

Heilongjiang General Hospital of Heilongjiang General Hospital of General Bureau of Agricultural Reclamationextensive-stage small cell lung cancer

Start: 2021-03-22Updated: 2021-09-07

Clinical trial of the efficacy and safety of Camrelizumab combined with chemotherapy in the treatment of advanced Pancreatic Adenocarcinoma

RecruitingChiCTR2100046966

Shandong Provincial Hospital???

Start: 2021-06-08Updated: 2022-01-18

Camrelizumab combined with chemotherapy for neoadjuvant treatment of esophageal cancer: a prospective, single arm, phase II clinical study

Active, not recruitingChiCTR2400086884

Tengzhou Central People's Hospitalesophageal cancer

Start: 2021-04-27Updated: 2024-07-22

Experimental group:Camrelizumab combined with chemotherapy

Sponsors

Conditions

Early Phase 1

Phase 2